Appointment of Directors
June 23 2006 - 9:25AM
UK Regulatory
RNS Number:0998F
Cambridge Antibody Tech Group PLC
23 June 2006
Cambridge Antibody Technology Group plc ("CAT")
CAT (LSE: CAT; NASDAQ: CATG) announces that, following the recommended offer
made by AstraZeneca UK Limited for CAT becoming unconditional in all respects on
22 June 2006, G H R Musker, S F Grady, I M D Brimicombe and A C N Kemp were
appointed Directors of CAT with effect from 22 June 2006. No further information
is required to be disclosed pursuant to Listing Rule 9.6.13.
For further information please contact:
Rowena Gardner, Director of Corporate Communications
+44 (0) 1223 898 622
This information is provided by RNS
The company news service from the London Stock Exchange
END
BOAAKNKBQBKDKAB
Catco Reinsurance Opport... (LSE:CAT)
Historical Stock Chart
From Sep 2024 to Oct 2024
Catco Reinsurance Opport... (LSE:CAT)
Historical Stock Chart
From Oct 2023 to Oct 2024